DPA
ELV icon

Delphi Private Advisors’s Elevance Health ELV Stock Holding History

Delphi Private Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15
Closed -$2K – 164
2016
Q4 		$2K Hold
15
– – ﹤0.01% 186
2016
Q3 		$2K Sell
15
-105
-88% -$13.6K ﹤0.01% 253
2016
Q2 		$16K Sell
120
-28
-19% -$3.83K 0.03% 108
2016
Q1 		$21K Buy
148
+26
+21% +$3.47K 0.04% 94
2015
Q4 		$17K Buy
+122
New +$16.8K 0.03% 115

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Delphi Private Advisors's ELV Position: Q1 2017 in Review

Delphi Private Advisors sold out of Elevance Health (ELV) in Q1 2017, closing a stake of 15 shares — an estimated $2K sold.

Delphi Private Advisors first reported a position in ELV in Q4 2015 and held it in 5 quarters. The position peaked at $21K in Q1 2016. 796 funds tracked by Wall St. Rank hold ELV as of Q1 2017.

  • Delphi Private Advisors reported no remaining Elevance Health position as of Q1 2017 after selling out during the quarter.
  • Delphi Private Advisors sold 15 Elevance Health shares in Q1 2017, an estimated $2K.
  • Delphi Private Advisors first reported a position in Elevance Health in Q4 2015 and held it in 5 quarters.
  • Delphi Private Advisors's Elevance Health position peaked at $21K in Q1 2016.
  • 796 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.

Based on Delphi Private Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.